Normal view MARC view ISBD view

[Preparation of electronic data processing in stomatology. 4. Periodontal status suitable for electronic data processing (pilot study)]. [electronic resource]

By:

Grimm, W D

Contributor(s):

Räntsch, P

Producer: 19730809Description: 179-87 p. digitalISSN:

0012-0790

Subject(s):

In: Deutsche Stomatologie vol. 23

Tags from this library: No tags from this library for this title. Log in to add tags.

Average rating: 0.0 (0 votes)

No physical items for this record

Publication Type: Journal Article

There are no comments on this title.

to post a comment.

Back to results

1 Electrocardiographic changes with ziprasidone.
by Loebel, Antony
2 Ziprasidone metabolism, aldehyde oxidase, and clinical implications.
by Beedham, Christine
3 The effect of food on the absorption of oral ziprasidone.
by Miceli, Jeffrey J
4 Tolerability of oral ziprasidone in children and adolescents with bipolar mania, schizophrenia, or schizoaffective disorder.
by DelBello, Melissa P
5 Pharmacokinetics, safety, and tolerability of intramuscular ziprasidone in healthy volunteers.
by Miceli, Jeffrey J
6 Single-dose pharmacokinetics and safety of ziprasidone in children and adolescents.
by Sallee, Floyd R
7 Effects of Oral Ziprasidone and Oral Haloperidol on QTc interval in patients with Schizophrenia or Schizoaffective disorder.
by Miceli, Jeffrey J
8 Pharmacodynamics of ziprasidone in children and adolescents: impact on dopamine transmission.
by Sallee, Floyd R
9 Effects of high-dose ziprasidone and haloperidol on the QTc interval after intramuscular administration: a randomized, single-blind, parallel-group study in patients with schizophrenia or schizoaffective disorder.
by Miceli, Jeffrey J
10 Adjunctive therapy with pregabalin in generalized anxiety disorder patients with partial response to SSRI or SNRI treatment.
by Rickels, Karl
11 The anxiolytic effect of the novel antipsychotic ziprasidone compared with diazepam in subjects anxious before dental surgery.
by Wilner, Keith D
12 A Phase 2 clinical trial of PF-05212377 (SAM-760) in subjects with mild to moderate Alzheimer's disease with existing neuropsychiatric symptoms on a stable daily dose of donepezil.
by Fullerton, Terence
13 A randomized, double-blind, 6-week, dose-ranging study of pregabalin in patients with restless legs syndrome.
by Allen, Richard
14 Comparison of pregabalin with pramipexole for restless legs syndrome.
by Allen, Richard P
15 Ziprasidone and the corrected QT interval: a comprehensive summary of clinical data.
by Camm, A John
16 Pregabalin versus pramipexole: effects on sleep disturbance in restless legs syndrome.
by Garcia-Borreguero, Diego
17 A randomized evaluation of the effects of six antipsychotic agents on QTc, in the absence and presence of metabolic inhibition.
by Harrigan, Edmund P